|
|
| Strategic Analysis of U.S. MicroRNA Services Markets |
|
| Table of Contents Published: 2009/03 Published by: Frost & Sullivan |
| This research service provides a strategic analysis of the microRNA services market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challe ... |
| The Top 60 Cancer Molecular Diagnostics Companies |
|
| Published: 2009/03 Published by: Research Facts Ltd. |
| Molecular diagnostic tests will increasingly be used for cancer screening, diagnosis, staging, therapy selection and relapse monitoring.
Molecular diagnostics is the fastest-growing segment of the in vitro diagnostics industry and cancer molecular dia ... |
| The Top 70 Molecular Diagnostics Manufacturing Companies In North America |
|
| Published: 2009/03 Published by: Research Facts Ltd. |
| Molecular diagnostics enables the early detection of diseases and conditions, the selection of targeted, individualised treatment options and the monitoring of treatment efficacy. Tests are available for a wide variety of diseases and conditions ranging f ... |
| Therapeutics and Diagnostics for Women's Disorders |
|
| Table of Contents Published: 2009/03 Published by: BCC Research |
| This newly updated BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the market for women' s therapeutic and diagnostic products. The geographical scope of this study is U.S. based. ... |
| U.S. Soft Tissue Repair Markets - Meniscus and Cartilage |
|
| Table of Contents Published: 2009/03 Published by: Frost & Sullivan |
| This research service studies the orthopedic soft tissue repair markets in the United States. The market is segmented as cartilage repair and meniscus repair markets. It covers the market from the aspects of the driving forces, restraints and challenges, ... |
| US Markets for Orthopedic Biomaterials 2009 |
|
| Table of Contents Published: 2009/03 Published by: Millennium Research Group |
| The US orthopedic biomaterial market, comprising bone graft substitutes, hyaluronic acid viscosupplementation, machined bone interbody devices, knee cartilage repair grafts and devices, and cell concentration systems was valued at nearly $2.5 billion in 2 ... |
| Apoptosis 2009: Opportunities in Cancer and Other Diseases |
|
| Table of Contents Published: 2009/02 Published by: Biophoenix Limited |
| Apoptosis is regarded as the major mode of cell death in cancer and should therefore be considered as a potential target when developing new antineoplastic drugs. An increasing number of companies are doing so, and we anticipate that this approach will pa ... |
| Biotech 2009-Life Sciences: Navigating the Sea Change |
|
| Published: 2009/02 Published by: BURRILL & COMPANY |
| Biotech 2009-Life Sciences: Navigating the Sea Change is the 23rd edition of this yearly publication. It provides a compass to guide you through the current financial market turmoil. The 400-plus page book contains analysis and perspectives on the perform ... |
| Cardiac Biomarkers |
|
| Table of Contents Published: 2009/02 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. ... |
| Chinese Markets for Autoimmune Drugs |
|
| Table of Contents Published: 2009/02 Published by: Asia Market Information & Development Co. |
| China' s demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, sup ... |
| Chinese Markets for Biopharmaceuticals |
|
| Table of Contents Published: 2009/02 Published by: Asia Market Information & Development Co. |
| China' s demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, s ... |
| Protease Inhibitors: Innovation Drives Drug Pipeline |
|
| Table of Contents Published: 2009/02 Published by: Insight Pharma Reports |
| Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteri ... |
| Stem Cell Therapeutics Markets |
|
| Table of Contents Published: 2009/02 Published by: Kalorama Information |
| Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward wit ... |
| Toxicity Screening 2009 Market Report |
|
| Table of Contents Published: 2009/02 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market metrics, and thorough bottom-up ba ... |
| Alzheimer's Disease Biomarkers, 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioPharm Reports (Technology and Markets Ltd) |
| This report gives a comprehensive and up-to-date review of Alzheimer' s disease biomarkers. Recent years have seen significant advances in this field. Whilst considerable effort has focused on AƒÀ and tau related markers, a substantial number of other mol ... |
| Analytical Tool - Apoptosis in Oncology |
|
| Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptopic drug development for the treatment of cancer. It is at the same time a map of the research and development ... |
| Analytical Tool - Protein Kinase Inhibitors in Oncology |
|
| Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Protein Kinase Inhibitors in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the s ... |
| Antibodies in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic anti ... |
| Apoptosis in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells. ... |
| Biologic Imaging Reagents: Technologies and Global Markets |
|
| Table of Contents Published: 2009/01 Published by: BCC Research |
| The study scope includes the biologic imaging reagents that are commercial or likely to be commercialized within the next five years. Fluorescent probes and dyes, imaging nanomaterials (including quantum dots and other nanoparticles), fluorescent proteins ... |
| Customized Health - US - January 2009 |
|
| Table of Contents Published: 2009/01 Published by: Mintel International Group Ltd, |
| Customized health - designing healthcare services based on the unique needs of consumers - is one of the most important trends in the healthcare category, and holds significant opportunities for companies that offer the right products and services. ... |
| Immunotherapy in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators ... |
| Royalty Financing Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/01 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.
The report provides a ... |
| Stem Cells for Cardiovascular Disease 2009 Market Report |
|
| Table of Contents Published: 2009/01 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects ... |
| The World Market for Molecular Diagnostics |
|
| Table of Contents Published: 2009/01 Published by: Kalorama Information |
| The various clinical techniques and trends are discussed from the point of view of their present and potential market impact.
Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe ... |
| Therapeutic Peptides in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Today, there are 124 companies plus partners developing more than 137 peptide based oncology drugs in more than 226 developmental projects. In addition, the accumulated number of ceased drugs over the last three years amount to another 56 drugs. In all, t ... |
|
|
Top
View Cart
